For the quarter ending 2025-09-30, CBIO made $27,163K in revenue. -$24,607K in net income. Net profit margin of -90.59%.
| Income Statement | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Research and development | 20,347 | - |
| General and administrative | 5,538 | - |
| Total operating expenses | 25,885 | - |
| Loss from operations | -25,885 | -21,030 |
| Interest income | 1,278 | 313 |
| Interest expense | 0 | 1,073 |
| Total other income (expense) | 1,278 | -760 |
| Net loss | -24,607 | -21,790 |
| Net loss and comprehensive loss | -24,607 | -21,790 |
CRESCENT BIOPHARMA, INC. (CBIO)
CRESCENT BIOPHARMA, INC. (CBIO)